跳至主要内容
临床试验/NCT06532370
NCT06532370已完成不适用

Implementing a Contingency Management Program Addressing Methamphetamine Use For and With the People of Hawaii

Queen's Medical Center1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2024年10月10日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
20
试验地点
1
主要终点
TEA Outcomes at 6 and 12-weeks

研究概览

简要总结

The goal of this clinical trial is to use contingency management (CM) as an intervention tool to address methamphetamine use.

The main objectives are to:

  • Gather effectiveness data on a pilot a CM program for participants in Hawaii who use methamphetamine following hospitalization due to traumatic injury
  • To assess participant perspectives on engaging with a CM program based at a Level 1 Trauma Center. Researches will assess both patient-reported and biologically-confirmed medium-term program effectiveness and conduct qualitative interviews with participants post-program.

Participants will:

  • Visit a follow-up clinic up to three times per week to complete urinalysis following discharge from the trauma unit
  • Complete Treatment Effectiveness Assessments at 6 and 12-weeks
  • Engage in a qualitative interview at the end of the CM program

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Admitted trauma patients
  • Age greater than 18 years old
  • Urine drug screen positive for methamphetamines during the current hospitalization
  • Report at least weekly methamphetamine use
  • First methamphetamine use greater than 6 months prior to injury
  • Report at least 4 DSM-V Amphetamine-Type Substance Use Disorder symptoms (at least moderate disease)
  • Glasgow Coma Scale ≥13 upon arrival to the emergency department
  • Ability to understand and participate in study procedures
  • Ability to communicate in English

排除标准

  • Active psychosis (reporting auditory or visual hallucinations)
  • Under ongoing cardiorespiratory monitoring
  • Evidence of moderate or severe traumatic brain injury
  • Patients who are known to be pregnant
  • Individuals incarcerated at the time of their hospitalization
  • Individuals lacking capacity to provide, or are otherwise unable or unwilling to provide written informed consent

结局指标

主要结局

TEA Outcomes at 6 and 12-weeks

时间窗: From enrollment to 6 and 12-weeks

Treatment Effectiveness Assessment (TEA): This assessment asks individuals to respond to changes in four domains following a drug treatment program: substance use, health, lifestyle, and community. The score for each domain can range from 1 (no change or not much) to 10 (much better), for a total score of 4-40. This score allows for the prioritization of each participants values, and therefore does not require strict abstinence to demonstrate benefit from drug treatment.

次要结局

  • Qualitative Outcomes(At the end of treatment at 12-weeks)

研究者

发起方
Queen's Medical Center
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验